4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-22-038538
President & CSO sold 51,015 shares at an average $42.70 ($2,178,229)
- President & CSO acquired 26,863 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciaramella Giuseppe President & CSO | 2022-12-12 | Option exercise | +18,211 | $0.67 | $12,201 | 133,825 | D |
| Ciaramella Giuseppe President & CSO | 2022-12-12 | Option exercise | +8,652 | $4.22 | $36,511 | 142,477 | D |
| Ciaramella Giuseppe President & CSO | 2022-12-12 | Sale | −31,699 | $42.30 | $1,340,868 | 110,778 | D |
| Ciaramella Giuseppe President & CSO | 2022-12-12 | Sale | −13,933 | $43.15 | $601,209 | 96,845 | D |
| Ciaramella Giuseppe President & CSO | 2022-12-12 | Sale | −5,383 | $43.87 | $236,152 | 91,462 | D |
| Derivatives | |||||||
| Ciaramella Giuseppe President & CSO | 2022-12-12 | Option exercise · Stock Option (Right to Buy) | −18,211 | 189,491 | D | ||
| Ciaramella Giuseppe President & CSO | 2022-12-12 | Option exercise · Stock Option (Right to Buy) | −8,652 | 4,326 | D | ||
| Open-market sales · 51,015 sh · avg $42.70 · $2,178,229 | |||||||
Loading xslF345X03/doc4.xml…